Skip to main content

ImmunityBio, Inc.

IBRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001326110

In the last 90 days, ImmunityBio, Inc. insiders filed 0 open-market purchases and 2 sales; 405 institutions reported holding it in 13F filings for Q2 2026, worth $1.76B in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding ImmunityBio, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of IBRX: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders1662194+30
Shares66.4M1.64M61.9M−2.90M (−4.5%)
Value$356.9M$8.78M$391.1M+$42.9M (+12.3%)

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (51)

Institutions that held ImmunityBio, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to IBRX in Q2 2024
InstitutionSharesValue% of portfolio
First Trust Advisors LP887,620$5.61M0.01%
Accurate Wealth Management, LLC560,000$3.56M0.85%
Woodline Partners LP437,843$2.77M0.03%
Balyasny Asset Management LLC207,196$1.31M0.00%
Cowen and Company, LLC200,000$1.26M0.04%
Clearstead Advisors, LLC188,500$1.19M0.02%
Readystate Asset Management LP124,885$789.3K0.04%
Mirae Asset Securities (USA) Inc.114,939$726.4K0.05%
Tudor Investment Corp Et Al101,046$638.6K0.01%
Brevan Howard Capital Management LP96,765$611.6K0.04%
Mirae Asset Global ETFs Holdings Ltd.83,109$528.9K0.00%
Bayesian Capital Management, LP82,100$518.9K0.06%
National Asset Management, Inc.81,550$515.4K0.01%
Corebridge Financial, Inc.76,240$481.8K0.00%
Collective Family Office LLC70,355$444.6K0.13%
Omers Administration Corp70,300$444.3K0.00%
HRT Financial LP67,782$428.0K0.00%
Squarepoint Ops LLC60,936$385.1K0.00%
Handelsbanken Fonder AB53,900$341.0K0.00%
Sanctuary Advisors, LLC36,840$270.8K0.00%
Verition Fund Management LLC40,663$257.0K0.00%
Schonfeld Strategic Advisors LLC34,626$218.8K0.00%
Gsa Capital Partners LLP27,667$175.0K0.01%
Kestra Private Wealth Services, LLC26,635$168.3K0.00%
Laurion Capital Management LP25,069$158.4K0.01%
Allianz Asset Management GmbH25,000$158.0K0.00%
J. Safra Sarasin Holding AG25,000$158.0K0.00%
Vontobel Holding Ltd.24,000$151.7K0.00%
Susquehanna Fundamental Investments, LLC23,185$146.5K0.00%
HB Wealth Management, LLC22,500$142.2K0.00%
Catalyst Funds Management Pty Ltd21,600$136.5K0.04%
Kapitalo Investimentos Ltda20,170$127.5K0.04%
Mercer Global Advisors Inc19,904$125.8K0.00%
CIBC Asset Management Inc18,704$118.2K0.00%
Integrated Wealth Concepts LLC17,158$108.4K0.00%
Dimensional Fund Advisors LP16,580$104.8K0.00%
Algert Global LLC13,560$85.7K0.00%
Alpine Global Management, LLC12,734$80.5K0.01%
Walleye Capital LLC10,522$66.5K0.00%
Buckingham Strategic Partners10,313$65.2K0.00%
Jefferies Financial Group Inc.7,500$47.4K0.00%
ZynergyRetirementPlanningLLC1,950$12.3K0.01%
GPS Wealth Strategies Group, LLC1,655$10.5K0.00%
Geneos Wealth Management Inc.847$5.35K0.00%
GWM Advisors LLC350$2.21K0.00%
Toth Financial Advisory Corp150$9480.00%
Thurston, Springer, Miller, Herd & Titak, Inc.100$6320.00%
HighMark Wealth Management LLC40$2530.00%
Headlands Technologies LLC22$1390.00%
Bessemer Group Inc50$00.00%
CWM, LLC13$00.00%

Sold out (21)

Institutions that held ImmunityBio, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Not filed for Q2 2024 yet (2)

Institutions that held ImmunityBio, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IBRX in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Credit Suisse AG1,548,826$8.32M
Winning Points Advisors, LLC92,786$465.8K